Life sciences
Stronger, tougher, cleaner: A*Star and local companies find new solutions in advanced manufacturing
Three new joint labs will develop new capabilities for high-value sectors such as aerospace and semiconductors
World-renowned chimpanzee expert Jane Goodall dies at 91
The British primatologist’s most famous finding is that chimpanzees use grass stalks and twigs as tools to fish termites from their mounds
DHL banks on burgeoning markets like South-east Asia as it aims for 50% revenue growth by 2030
Tariffs or not, it has set aside billions for expansion and sees huge potential in life sciences and e-commerce
Investing in synthetic biology: Rewriting life’s code
The field promises to redefine the future of food and materials, but it also presents a host of ethical dilemmas, regulatory hurdles, and risks of unforeseen consequences that investors must carefully...
AcroMeta to divest life-sciences business, pursue minerals trading business
ACROMETA intends to divest its life-sciences business as part of a review of its long-term strategy, the specialist engineering firm said on Monday (Oct 21).
Germany’s Merck open to more M&A for its Life Science division
GERMAN science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for US$600 million, it said ahead of its Capital Mar...
Ho Bee Land sells 49% stake in Elementum for S$134 million to sovereign wealth fund
The company says the deal paves the way for broader collaboration, exploring new avenues for strategic growth and development
First human to receive transplanted pig kidney dies
A MAN with end-stage renal disease who earlier this year became the first human to receive a new kidney from a genetically modified pig has died, Massachusetts General Hospital in Boston said.
Belgian whose body brews alcohol beats drink-driving rap
A BELGIAN man with a very rare metabolic condition that causes his body to produce alcohol had a drink-driving charge against him dismissed in court on Monday (Apr 22).
Local life sciences sector faces gap in late stage capabilities
THE life sciences sector in Singapore is facing a gap in late stage capabilities of biotech companies here, which could hinder them in the future.
